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BIOCHEMICAL ASPECTS OF PANCREATITIS* *
In its acute forms, pancreatitis is a severe and frequently fatal disease,
characterized biochemically by intrapancreatic activation of very powerful
digestive enzymes.'0 The activation of these enzymes results in hydrolytic
cleavage of cellular structures followed by generalized pancreatic necrosis,
peritonitis, and vasomotor collapse."'8 In its chronic forms, pancreatitis is
a disabling disease associated with progressive digestive insufficiency due to
decreasing concentrations of pancreatic enzymes in the intestinal contents.'8
Accordingly, malnutrition, anemia, and avitaminosis accompany the recur-
rent epigastric pain which results from localized pancreatic inflammation.
INTRACELLULAR METABOLISM OF THE PANCREAS
The enzymes and external secretion of the pancreas are produced by the
acinar cells.' For an adequate understanding of pancreatitis, a great deal
must be learned about the specific metabolism of these cells, inasmuch as at
present there are relatively few established facts. The oxidative metabolism
of the pancreas is apparently very similar to that of other tissues as indi-
cated by (i) a Q02 for pancreas slices of 6-7;18 ' (ii) accumulation of
citrate in the pancreas of the fluoroacetate-treated animal; and (iii) accumu-
lation of isotope of labeled acetate and labeled pyruvate in the glutamate
pool of the pancreas."' Evidence for very active protein synthesis has been
obtained from studies in which isotopically labeled amino acids have been
injected into animals in vivo. In the rat, labeling of protein with isotopically
labeled lysine or glycine was greater in the pancreas than in any other
tissue studied;" in the dog, only the duodenal mucosa was as active in
labeling of protein.'0 The quantity of protein produced by the human pan-
creas has been calculated as 10-20 grams, i.e., one to two liters of exocrine
secretion daily with a 1-2 per cent concentration of enzymes." '2021 In some
animals 20 per cent of the dry weight of the gland consists of enzymes with
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trypsin, amylase, lipase, and ribonuclease comprising 10, 5, 23/2, and /2
per cent respectively of the dry weight." Attempts to study synthesis of
pancreatic enzymes in vitro have only gone as far as demonstration of
enzyme synthesis by pancreatic slices. Hokin initially injected animals with
cholinergic compounds to deplete the pancreas of enzymes;`' he then
incubated pancreas slices in media supplemented with amino acids, and
found that the enzymatic concentration increased in the medium after the
slice had been stimulated with carbamyl choline.
THE EXOCRINE SECRETION OF THE PANCREA
As indicated in Table 1, the exocrine secretion of the pancreas contains
a variety of hydrolytic enzymes, including the peptidases, trypsin, chymo-
trypsin, and carboxypeptidase, the glycosidases, amylase and maltase, the
esterases, cholesterol esterase and lipase, and the nucleases, ribonucleases
and deoxyribonuclease.'
Peptidases. Trypsin and chymotrypsin are normally present in the pan-
creas as the inactive precursors, i.e., trypsinogen and chymotrypsinogen.
Activation of both enzymes results from hydrolysis of a "protective" peptide
from the main enzyme molecule. Trypsinogen is a protein which contains
the peptide chain, valyl -aspartyl-aspartyl-aspartyl-aspartyl-lysyl-isoleucine;
in its activation to trypsin by trypsin, hydrolysis of the lysyl-isoleucyl bond
results in the liberation of the active trypsin and the free hexapeptide, valyl-
aspartyl-aspartyl-aspartyl-aspartyl-lysine.' In the duodenum and jejunum,
trypsinogen is converted to active trypsin by the enzyme enterokinase." "'1l
The mechanism of the activation is not established, but is not simply a
release from the inhibition of pancreatic trypsin inhibitor." Since trypsin
itself can activate trypsinogen as noted above, the process is autocatalytic
once started; calcium ion is an activator for the reaction."'" Trypsin is an
endopeptidase attacking proteins either at the center or ends of the molecule
at peptide bonds of the basic amino acids, arginine, and lysine on the amide
linkage joining the carboxyl of these amino acids to the adjacent amino acid
(Table 1).9 The proteolytic activity of trypsin has been applied therapeuti-
cally for enzymatic debridement of ulcerating or other chronic infections.'
Chymotrypsinogen is a precursor of the proteinases grouped as chymo-
trypsin (Table 1). In the course of its activation by trypsin, the "protective"
peptide side chain is split off gradually resulting in a series of active chymo-
trypsins, including alpha, beta, and gamma chymotrypsins," pi chymotryp-
sin,U and delta chymotrypsin."8 Alpha chymotrypsinogen is a crystalline
compound containing a peptide chain, leucyl-seryl-arginyl-isoleucyl-valine.
In the pi chymotrypsin, the terminal isoleucyl-valine dipeptide has been
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split off the parent protein, while the delta form is the result of the loss of
the seryl-arginine dipeptide." The chymotrypsins differ from trypsin in their
ability to clot milk; their substrate specificity is also different from that of
trypsin, since they require either an aromatic ring, such as that found in
tryosine,9 phenylalanine, and tryptophan or methionine"8 adjacent to the
peptide bond which they attack.
Carboxypeptidase. In addition to the endopeptidases, trypsin and chymo-
trypsin, the pancreas also secretes carboxypeptidase, an exopeptidase which
attacks only terminal peptide bonds. This enzyme attacks the terminal pep-
tide bond of a chain of amino acids at the carboxyl end of a polypeptide.'4
Trypsin inhibitors. The first of the trypsin inhibitors was isolated and
crystallized from pancreas by Kunitz and Northrop and was shown to com-
bine with trypsin stoichiometrically to yield a third protein possessing no
proteolytic activity.' Inhibitors of trypsin have been isolated from a variety
of sources, including soybeans, lima beans, and intestinal parasites such as
Ascaris.64" 90 These compounds are polypeptides or proteins with molecular
weights ranging from 8,000-40,000 and they are thought to combine with
trypsin in a 1: 1 ratio. The tenacity of their binding with trypsin is evident
from the dissociation constant of the trypsin-inhibitor (pancreatic) com-
plexes which have been estimated as 2 x 10"° M.-8-0 64, The inhibition was
originally thought to be noncompetitive, but Green has shown that the ethyl
ester of the substrate, benzoyl-L-arganineamide, protects the enzyme against
the pancreatic inhibitor. Green also found that DFP (diisopropylfluoro-
phosphate), which itself inhibits tryptic activity, protects the enzyme against
combination with the pancreatic inhibitor and suggested that the inhibitor
combines with the enzyme at the "active site."e"
' Chymotrypsin is also
inhibited by DFP.
Tests of tryptic activity. Two clinical methods are useful for testing for
intestinal activity of this enzyme group. In the first, hydrolysis of gelatin is
measured either by a viscosimetric procedure which estimates liquefaction of
gelatin5 or by the clearing of a spot on the x-ray film by a known dilution of
a fecal suspension." In each instance, a negative test is of little significance,
since trypsin itself is hydrolyzed in the passage of the intestinal contents
through the gut. The methods are most applicable in pediatric practice,
since the stools of infants are generally soft and moist; in the adult, desicca-
tion and hardening of the stool is associated with destruction of the enzyme.'
A second method for the determination of proteolytic activity is the study
of the stool for meat fibers (creatorrhea).7' This test is of some use in
testing for pancreatic insufficiency.
598
Volume 29, June 1957Biochemical aspects of pancreatitis I BUSCH
u)
OU tg
1 O 4i t=
_ U ce
.4
*e b
*n gC lo
.~~~~~ ..
bO
Cd 0~~4)
Cv
I0C) al la = -4D i-i
ci 0 _
C) c4 O P4 C o
i - 4 4.= la
+
.9 cn
:L
.4
0)
In 0@ t S
1¢ 2 H O
-4
.2
4) I-0
4)
Cl)
c.l M O
0 ..
0-U
LI)
V) -R
+ +Ca
bO
)
b4 bO
In
4)
e .4 a
p:;
X 0 2
Cd
*_4
I
u uIi)
0 Co
2 n r.I 9 sc
0
_ N
-.
Co 4)
r ,= 4)- n
2.
lit:s
ItQ
.41.1
t.)
a
C3
r.
4z
cq
I; .t2
9
-t
t4
I;
- b
4z,
1166
:9
Iz
Cb
I"
4z.
"V
-.91
C.
144
ts 1;5 .9
ti
'11:.
Co z
0
LI)
C.)
CE)
H-
x 0 2-
4)CI
59YALE JOURNAL OF BIOLOGY AND MEDICINE
Glycosidases. The most important of the pancreatic glycosidases is the
enzyme pancreatic amylase (Table 1).' This enzyme has a molecular
weight of 45,000 and has the characteristics of an alpha amylase, i.e., it
attacks the internal bonds of the polysaccharide and does not release single
glucose units.' The enzyme specifically attacks the a-1, 4-glucosidic bond
and exhibits no significant activity on structures with the 8-glycosidic
linkage. Pancreatic amylase hydrolyzes starch to maltose and trisaccharides
and is activated fourfold by the addition of chloride ion. As far as can be
determined, pancreatic amylase is the same enzyme as salivary amylase. The
products of the hydrolytic activity of pancreatic amylase are hydrolyzed to
glucose by maltase.
Testsfor amylase activity. The clinical methods applied to the determina-
tion of amylase activity at present are "saccharogenic" or "amyloclas-
tic."''' The method of Somogyi determines the quantity of glucose or
reducing sugar liberated from an excess of buffered starch in 30 minutes at
380 C. The results, expressed in terms of mg. of glucose liberated per 100
cc. serum, are 70-200 Units for normal serum. In the "amyloclastic" method
of Wohlgemuth, a series of dilutions of the serum are incubated with a
limiting quantity of starch substrate for 30 minutes at 380 C. At the end of
the incubation the degree of hydrolysis of the starch in each tube is deter-
mined by addition of a drop of iodine; the highest dilution of serum which
results in a colorless solution on the addition of iodine is the end-point; the
inverse of the dilution is reported as the number of units in the serum.
Normally, 8-16 Wohlgemuth units of amylase activity are present per 100
cc. of serum. Both methods are quite reliable as indexes of amylase activ-
ity, but there seems little to choose between the two methods, inasmuch as
the Somogyi procedure has the advantage of sensitivity, while the Wohl-
gemuth procedure has the virtue of simplicity.
Lipase. Pancreatic lipase is an esterase which is apparently the only lipase
secreted in significant quantity or activity in the gastrointestinal tract. In
general, it is. more active toward triglycerides containing long chain, un-
saturated fatty acids. The end-products of its activity are a mixture of
diglycerides, monoglycerides, fatty acids, and glycerol. The optimum pH
for the enzyme is 7-8 and the activity is enhanced by the addition of bile
salts, calcium ion, and various peptides to the medium. Following the report
of Elman on the usefulness of amylase studies for diagnosis of pancreatic
inflammation, Cherry and Crandall reported an increase in plasma lipase
activity in pancreatic obstruction.22 The technique used for determination of
the activity of the enzyme requires a 24-hour incubation of 5 cc. of a buf-
fered suspension of olive oil with 1 cc. of serum at 40' followed by titration
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of the liberated fatty acids. Unfortunately, the long incubation period has
precluded the use of this technique as a routine procedureq' and more soluble
substrates are being sought in an effort to shorten the required incubation
time.`nl In chronic pancreatic insufficiency, the lack of pancreatic lipase
results in steatorrhea and the excretion of foul, greasy stools. The fat may
be seen microscopically by staining the stool with Sudan IV or it may be
determined gravimetrically;7 an increase in the percentage of lipid from the
normal value of 10-20 to 40-50 per cent of the total dry weight of the stool
is very suggestive of pancreatic disease.' -'-'
In addition to the enzymes discussed above, the pancreatic secretion con-
tains enzymes which have been less extensively studied, both from a clinical
or biochemical point of view; these include cholesterol esterase, ribonucle-
ase, and deoxyribonuclease. The endocrine secretion of the pancreas con-
tains two other polypeptides, insulin and glucagon, but these play no
apparent role in pancreatitis.
The inorganic compounds secreted by the pancreas are chiefly water and
the ions normally found in the serum. Under the influence of secretin, the
secretion of water increases markedly, and the bicarbonate ion concentration
rises to the level of the chloride ion, i.e., from 6-30 mEq./liter to 120-130
mEq./liter, while the chloride ion concentration drops from 120 mEq./liter
to 28 mEq./liter.`"`' In the secretin test for the study of pancreatic secre-
tion, the average volume of secretion is 250 cc., generally containing 32
mEq. of base as alkali reserve. In the test meal for gastric acidity, an aver-
age of 180 cc. of 0.1 N base are required to neutralize the gastric secretion,
i.e., 18 mEq. of acid are formed. The approximate equivalence of these
values has been the source of speculation on the role of the pancreas in
maintaining the normal duodenal pH and preventing peptic ulcer.59' It is
thought that the circulating blood is the source of the bicarbonate of the
pancreatic secretion, inasmuch as C1402 injected into secretin-treated ani-
mals appears promptly in the pancreatic secretion. Although the mechanism
of transfer of the bicarbonate from the blood to the pancreatic secretion is
unknown, it is suspected that carbonic anhydrase may play an important
role, inasmuch as Diamox ® inhibits both the increase in bicarbonate as
well as the increase in total volume.2
PHYSIOLOGICAL CONTROLS OF THE EXOCRINE SECRETION
Secretin. Pavlov and his co-workers found that the flow of pancreatic
secretion was initiated by the entry of gastric contents into the duodenum."'
They also found that the pancreatic secretion varied with the diet, so that
animals fed bread exhibited increased amylolytic activity, while a meat diet
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evoked the maximum tryptic activity. While this challenging observation
has not been explained, it has been verified by other workers since that
time.' Bayliss and Starling found that the increase in secretion evoked by
acid was mediated by secretin,9 a polypeptide hormone formed by the duo-
denal mucosa and released into the blood stream in the presence of acid.
Secretin has been crystallized and has been found to have a molecular
weight of 5,000.7' Its amino acid composition has been studied by Agren
and Willander who found that it contained much lysine'and arginine, but
no cystine, tyrosine, or tryptophan.8
Secretin test for pancreatic function. The chief effects of secretin are the
increases in volume and bicarbonate content of the pancreatic secretion and
these effects are the parameters used in the secretin test for pancreatic
function introduced clinically by Agren and Lagerlof."2' Following the
intravenous injection of 0.75 mg/kg or 1 U/kg of the hormone, collection of
the pancreatic secretion is carried out via a biluminal tube for an 80-minute
period, in 1, 2, or 4 equal parts;"`o2 @ the outer lumen of the tube separates
gastric secretion from the duodenal contents which are collected from the
center lumen. The response should include the secretion of a volume of
125-250 ml., with a bicarbonate concentration of 90-130 mEq./l., 90-1,200
U. of amylase, 20-120 U. of trypsin, and 7,000-14,000 U. of lipase.''"9'
Vagal stimulation. The physiological controls of the secretion of pancrea-
tic enzymes have been less extensively studied. Mellanby and others noted
that stimulation of the vagus nerves or administration of cholinergic com-
pounds results in the secretion of a small quantity of fluid rich in en-
zymes;'-9' this secretion was found to be accompanied by discharge of
zymogen granules of the pancreatic acinar cells. Similar effects have been
obtained by the hormone pancreozymin which has been isolated from the
small intestine by Harper and Raper."' The relative role of the nerve
impulses and hormones is not yet evaluated.
PATHOGENESIS
The acute inflammatory diseases of the pancreas are acute pancreatic
necrosis (acute hemorrhagic pancreatitis) and acute interstitial pancreatitis
(acute pancreatic edema). The significant development in pancreatitis is the
release of free trypsin in the pancreatic acini or cells. The evidence for the
key role of trypsin was obtained in experiments of Polya and Rich and
Duff.' In 1905 Polya reported that the injection of as little as 1 ml. of
a solution of trypsin into the pancreatic duct of dogs resulted in fatal acute
hemorrhagic pancreatitis, while injection of greater volumes of inactivated
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preparations did not result in such lesions. Rich and Duff pointed out that
trypsin, unlike pepsin, produced severe local hemorrhage,2'
' edema, and
necrosis.
Mechanism of release of trypsin. The basic question in the etiology of
pancreatitis is what is the mechanism of activation and/or release of the
trypsin? Kunitz has shown that crystalline trypsinogen continuously under-
goes spontaneous breakdown to yield trypsin and this process is catalyzed
by ammonium sulfate or magnesium sulfate.8' If this process were not
rapidly and effectively suppressed in the pancreatic cells, acute pancreatitis
would be a far more common clinical event than it is at present. A relatively
small number of trypsin molecules would "autocatalyze" activation of a
progressively increasing number of molecules to trypsin and chymotrypsin.8'
It can be presumed that the large quantity of very effective pancreatic tryp-
sin inhibitor suppresses this process in its inception. Evidence for this con-
cept has come from studies of Kalser and Grossman who produced pan-
creatitis by daily administration of ethionine, an analogue inhibitor of
methionine metabolism.8' They found an increase in the concentration of
active trypsin in the pancreatic secretion and in the pancreas. Significantly,
they found a depression in the ratio of the concentration of trypsin inhibitor
to trypsin, both in the pancreatic secretion and in the pancreatic tissue.
These studies do not provide insight into the mechanism of reduction of
trypsin inhibitor in human pancreatitis. However, a number of other theories
for pancreatitis relate indirectly to this question. The older theories of patho-
genesis of pancreatitis include: (i) the "obstruction-hypertension theory"
which suggests that the pressure is elevated in the pancreatic ducts and
function is suppressed by the ensuing increased cellular pressure;21l15l141O
(ii) the "common channel theory" which suggests that there may exist a
common channel between the bile ducts and the pancreatic ducts with bile
acting as a hypothetical activating agent for trypsin;` 9 and (iii) the "over-
secretion" theory which is supposed to account for the relationship of pan-
creatitis to alcoholism.84 "'' ' 0 Each of these possibilities may account for
a temporary cessation of formation of trypsin inhibitor. If this inhibitor is
normally the rate-limiting factor for activation of trypsinogen, its absence
would result in a sudden increase in active trypsin in the gland, and thereby
set off the whole hydrolytic process.
The chronic inflammation of the pancreas, chronic relapsing pancreatitis,
is divided into two stages of recurrent pancreatitis and pancreatic insuf-
ficiency. Recurrent pancreatitis is considered to be a more localized acute
interstitial pancreatitis, while the end-stage of pancreatic insufficiency
results from fibrosis of the pancreas (Table 2).
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TABLE 2.
Pathogenesis Clinical signs Laboratoryfindings Therapy
ACUTE PANCREATIC INFLAMMATION
violent epigastric
pain
I. Intrapancreatic
decreased
Trypsin inhib.
1. tryptic hy-
drolysis of
gland, edema
2. peptone for-
mation,
hemorrhage
3. lipolysis,
calcium soaps
II. Extrapancreatic
1. Intraperitoneal
enzymes
a. omental fat abdominal pain,
necrosis nausea, vomiting,
distention, rigidity
b. peritoneal ileus
irritation
2. Plasma en-
zymes
1. Meperidine, opiates
2. Nerve blocks
3. Atropine-like drugs
shock,hyperthermia
depressed serum Ca
increased levels of
pancreatic enzymes
in peritoneal fluid
x-ray: ileus
amylase: 500-
3000 U.
lipase: 5-15 U.
increased urinary
amylase, lipase
shock (peptones?)
Blood, plasma, fluid
and electrolyte
20% calcium lactate
I.v.
Pancreatic rest:
nothing orally, naso-
gastric suction, pheno-
barb., atropine-like
drugs
Trypsin inhibitor?
3. Bacterial
invasion,
cholangiitis,
abscess
jaundice, sepsis For secondary infec-
tion: penicillin, aureo-
mycin, terramycin
CHRONIC PANCREATIC INSUFFICIENCY
I. Insufficient malnutrition, increases stool fat
lipase steatorrhea decreased fatty
acids
II. Insufficient
tryptic activity
anemia
high caloric diet, pan-
creatic enzymes (pan-
creatin, N.F.)
creatorrhea, azo- raw pancreas?
torrhea
III. Fibrosis, palpable pancreas, glycosuria, x-ray
calcification diabetes calcification
NPH insulin
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CHEMICAL PATHOLOGY OF PANCREATITIS
Acute pancreatitis. The destruction of pancreatic tissue by proteolytic
enzymes not only produces hemorrhage and necrosis,1'" but also liberates
an active pool of other enzymes, including pancreatic lipase. The release of
lipase is accompanied by hydrolysis of fat of the pancreatic tissue, the omen-
tum and the mesentery. The freed fatty acids rapidly form insoluble calcium
soaps by combination with calcium ion of the circulating blood.u' The
formation of calcium soaps depletes the calcium ion in the plasma as was
shown by Edmondson and Fields who found 100-1730 mg. of calcium in the
pancreas of patients with pancreatitis.' Inasmuch as there is approximately
10 mg. calcium per 100 cc. plasma, the total in the blood of a 70 kg. man
would be 350 mg. in 3.5 liters of plasma. The extracellular fluid contains
approximately 5 mg./100 cc. or 575 mg. in 11.5 liters. Accordingly, the
combined total for plasma and extracellular fluid is 925 mg. The large
reservoir of calcium in the bones could easily replace the losses from the
plasma and extracellular fluid in time, but the rate of replacement generally
does not equal the rate of depletion. Edmondson and Berne found that the
plasma level of calcium dropped to less than 9 mg./100 cc. in 72 per cent of
cases studied and in a number of cases, levels of less than 7 mg./100 cc. were
noted; tetany has been reported.""7
Serum levels of enzymes. The studies of Elman and coworkers, first
reported in 1929, established the importance of the determination of the
concentration of amylase in the blood for the diagnosis of acute pancreati-
tis."' It has been pointed out that normally all exocrine enzymes of the
pancreas are found in small amounts in the blood;' however, pancreatitis
alters the so-called "exocrine-endocrine partition" in the direction of an
increased blood amylase, lipase, and possibly trypsin concentration. Elman
et al. measured the rate of decrease in the viscosity of a starch solution as
an indication of the concentration of amylase; they found an increase of 2-
to 20-fold in activity of amylase in the serum of patients with acute pan-
creatitis. In terms of modern analytical values, the serum amylase increases
from an average value of 150 Somogyi Units/100 ml. plasma to more than
500 U/100 ml. of plasma, and maximum values of 8,000 U/100 cc. plasma
have been reported.'" In acute pancreatitis, these values remain elevated
for 48-72 hours and then decrease to a normal level." The pancreatic
amylase is excreted by the kidney and within two hours after the serum
level has risen, the level in the urine increases; a confirmatory test for pan-
creatitis has been developed utilizing the urine amylase level.""' v" A marked
rise in lipase of the blood is also noted and the level of this enzyme remains
elevated for a considerably longer time than does the amylase level.'''
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This test for pancreatic inflammation has been reported as 95-97 per cent
positive. Thus far, a significant increase in trypsin level in the blood has not
been found. It may be that the trypsin inhibitor in the blood complicates
accurate estimation of this enzyme in the blood.`q'
Chronic pancreatitis. In chronic pancreatitis, the progressive destruction
of acinar tissue results in a decreased secretion of pancreatic enzymes. A
similar pancreatic insufficiency is found in cystic fibrosis of the pancreas.'
Steatorrhea, azotorrhea, and creatorrhea result in the formation of a bulky,
greasy, foul stool, weight loss, and polyphagia."'0' Amylorrhea is not found,
indicating the presence of adequate digestive enzymes for polysaccharides in
the intestinal secretions. The presence or absence of creatorrhea, simply
determined by observation of undigested meat fibers in the stool, may also
be of significance in differential diagnosis of biliary deficiency and sprue,
since creatorrhea does not accompany these diseases. The percentage as
"split fat," or fatty acids, is low in pancreatic disease and this may be a use-
ful point in differentiating sprue or biliary deficiency.""''' A result of
steatorrhea is deficient absorption of fat soluble vitamins. After administra-
tion of Vitamin A to control subjects, the level in the plasma increased to
300 micrograms/100 ml. plasma from a control level of 50-100 micrograms/
100 ml.' In contrast, a failure of increase in the plasma level of Vitamin A
was noted in patients with cystic fibrosis of the pancreas or celiac disease.
Administration of pancreatin resulted in a marked increase in the level of
Vitamin A in the plasma of patients with cystic fibrosis of the pancreas.
THERAPY
Acute pancreatitis. Since there are no readily available specific inhibitors
for pancreaticenzymes,"
--` the therapy for acute pancreatitis is primar-
ily supportive."' "' ' This supportive therapy can be summarized in four
basic principles: (i) relief of pain, (ii) inhibition of pancreatic secretion,
(iii) restoration of nutritional, fluid, and electrolyte balance, and (iv) pre-
vention of infection (Table 2)."
' = Surgical procedures are limited to
complications of the disease."'eFor relief of pain,' meperidine (Demerol)
or opiates are administered parenterally, and local anesthesia has been em-
ployed by means of epidural, paravertebral, and splanchnic nerve blocks. To
suppress liberation of secretin, oral feeding is prohibited and nasogastric
suction is instituted. Vagal stimulation of the pancreas and the sphincter of
Oddi is depressed by administration of atropine and atropine-like drugs.""'
Fluids and electrolytes are administered in quantities sufficient to com-
pensate both for the daily secretions and the gastric aspirations. Blood cal-
cium levels are maintained at normal values by administration of 10 per cent
606
Volume 29, June 1957Biochemical aspects of pancreatitis I BUSCH
calcium gluconate. Blood or plasma are used to treat attendant shock.'"
For therapy of secondary infections, antibiotics have been used either singly
or in combination. Supportive therapy with cortisone and ACTH has also
been studied.'0 ' In the recovery period, antacids are administered and
stimulants of gastric secretion, such as coffee and alcohol, are omitted from
the diet.
Chronic pancreatitis. In the various forms of pancreatic insufficiency,
maintenance of nutrition is an important part of medical therapy. Replace-
ment therapy with pancreatic enzymes has been used to combat the severe
weight loss which accompanies pancreatic insufficiency. Raw pancreas or
enteric coated pancreatin (N.F.) is administered orally in doses of 10-20
grams daily." While excellent amylolytic, lipolytic, and proteolytic activ-
ity has been reported for some preparations of pancreatic enzymes, carefully
controlled studies on their fate and effectiveness are uncommon. The re-
mainder of therapy is symptomatic and designed to prevent further attacks.
Surgery has a limited role in therapy of chronic pancreatic inflamma-
tion." """' Atropine-like drugs and analgesics may be utilized for relief
of distress. Antacids may be administered and alcohol is prohibited. The
mild diabetes which occasionally occurs is readily controllable with low
doses of insulin.'
In summarizing therapy of pancreatitis, it is apparent that marked gaps
exist between biochemical knowledge of normal pancreatic function, patho-
genesis, and chemical pathology of the disease on the one hand, and the
availability of specific therapeutic agents on the other. As biochemical
pharmacodynamics advances, it seems reasonable to hope that useful drugs
will become available which will inhibit the necrotizing effects of trypsin and
other released pancreatic enzymes in acute pancreatitis. A more readily
approachable problem would be the development of methods for preparation
of very active purified enzymes for treatment of chronic pancreatitis.
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